Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC Study
- 1 August 2005
- journal article
- research article
- Published by American Academy of Pediatrics (AAP)
- Vol. 116 (2) , 360-369
- https://doi.org/10.1542/peds.2004-1172
Abstract
Background. Guidelines recommend daily controller therapy for mild persistent asthma. Montelukast has demonstrated consistent benefit in controlling symptoms of asthma and may be an alternative, orally administered, nonsteroidal agent for treating mild asthma.Keywords
This publication has 27 references indexed in Scilit:
- Evidence for the Increase in Asthma WorldwidePublished by Wiley ,2007
- Safety of the Newer Inhaled Corticosteroids in Childhood AsthmaPediatric Drugs, 2003
- Non‐inferiority trials: advances in concepts and methodologyStatistics in Medicine, 2002
- Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trialJournal of Allergy and Clinical Immunology, 2001
- Efficacy and safety of dry powder fluticasone propionate in children with persistent asthmaAnnals of Allergy, Asthma & Immunology, 2000
- Low‐dose inhaled budesonide once or twice daily for 27 months in children with mild asthmaAllergy, 2000
- Validation of an asthma symptom diary for interventional studiesArchives of Disease in Childhood, 1999
- Changing prevalence of allergic rhinitis and asthmaAnnals of Allergy, Asthma & Immunology, 1999
- Fluticasone propionate 50 μg BID versus 100 μg BID in the treatment of children with persistent asthmaClinical Therapeutics, 1998
- Growth in asthmatic children treated with fluticasone propionateThe Journal of Pediatrics, 1998